Elevated levels of Lp-PLA2 associated with increased risk of coronary heart disease

Links shared publicly online about this topic.

1,155
total visits

Elevated levels of Lp-PLA2 associated with increased risk of coronary heart disease

A meta-analysis of approximately 80,000 individuals from 32 prospective studies was published in The Lancet on May 1, 2010. The data shows that elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory enzyme, are associated with an increased risk of coronary heart disease similar in magnitude to that with non-HDL cholesterol or systolic blood pressure.

View full resource at news-medical.net

Tags: Heart, Heart Disease, Coronary Artery Disease, Cholesterol, Stroke, Thrombotic Event, Disease and Condition

Most Recently Shared on May 20, 2010 at 2:27 pm By:

News-Medical.Net

Stroke News: Elevated levels of Lp-PLA2 associated with increased risk of coronary heart disease: A meta-analysi... http://twurl.nl/ididy0

2 years ago...

Retweet

Favorite

Scientist Identifies Protein That May Reduce Risk of Heart Disease

newswise.com — “Children's Hospital Oakland Research Institute scientists identified that an injection of the protein apolipoprotein (apo)A-V may reduce high triglyceride levels in the blood and subsequently reduce coronary artery disease. Like cholesterol, elevated levels of triglyceride, a fat in the blood, is associated with the increased risk of heart disease"the number one cause of death in the United States.” View full resource at newswise.com